Cargando…
(18)F-FDG PET/CT Imaging In Oncology
Accurate diagnosis and staging are essential for the optimal management of cancer patients. Positron emission tomography with 2-deoxy-2-[fluorine-18]fluoro- D-glucose integrated with computed tomography ((18)F-FDG PET/CT) has emerged as a powerful imaging tool for the detection of various cancers. T...
Autores principales: | Almuhaideb, Ahmad, Papathanasiou, Nikolaos, Bomanji, Jamshed |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101722/ https://www.ncbi.nlm.nih.gov/pubmed/21245592 http://dx.doi.org/10.4103/0256-4947.75771 |
Ejemplares similares
-
COVID-19 in the act: incidental 18F-FDG PET/CT findings in asymptomatic patients and those with symptoms not primarily correlated with COVID-19 during the United Kingdom coronavirus lockdown
por: Halsey, Richard, et al.
Publicado: (2020) -
The impact of infection and inflammation in oncologic (18)F-FDG PET/CT imaging
por: Rahman, W. Tania, et al.
Publicado: (2019) -
Impact of combined (18)F-FDG PET/CT in head and neck tumours
por: Syed, R, et al.
Publicado: (2005) -
Applications of artificial intelligence in oncologic (18)F-FDG PET/CT imaging: a systematic review
por: Sadaghiani, Mohammad S., et al.
Publicado: (2021) -
Evolution of (18)F-FDG PET/CT Findings in Patients After COVID-19: An Initial Investigation
por: Thornton, Andrew, et al.
Publicado: (2022)